Introduction
The trade-off we're examining today is whether Greenway Health should prioritize enhancing the user interface of its Prime Suite EHR or focus on adding more advanced clinical decision support features. This scenario involves balancing user experience improvements against the addition of potentially valuable clinical tools. I'll approach this analysis by examining the product context, stakeholder impacts, and potential outcomes of each option.
I'd like to outline my approach to ensure we're aligned on the structure and focus of this discussion.
Step 1
Clarifying Questions (3 minutes)
Why it matters: Helps prioritize UI enhancements against potential user loss Expected answer: Mixed feedback, with some users complaining about interface complexity Impact on approach: Would influence the urgency and scope of UI improvements
Why it matters: Determines the strategic importance of new clinical features Expected answer: We're slightly behind in some advanced clinical decision support areas Impact on approach: Would justify prioritizing new clinical features if we're significantly behind
Why it matters: Helps align product improvements with revenue goals Expected answer: Considering a tiered pricing model based on feature set Impact on approach: Could influence which features to prioritize for different user segments
Why it matters: Assesses feasibility and potential timeline for each option Expected answer: Stronger in UI/UX, but building capabilities in clinical algorithms Impact on approach: Might favor UI improvements in the short term while building clinical expertise
Why it matters: Ensures compliance and avoids potential legal issues Expected answer: New regulations coming for AI-driven clinical decision support Impact on approach: Might necessitate focus on clinical features to maintain compliance
Practice similar questions
Subscribe to access the full answer